Turnaround Opportunity Zimmer Biomet - AI Robotics Opens Up Revaluation Potential

According to Grand View Research, the global market for surgical robotics, including instruments and accessories, is expected to grow from $17.2 billion in 2026 to $45.6 billion by 2033 – nearly 15% annually!
Andreas Zehetner
A. Zehetner
Reading Time: 2 minutes

Zimmer Biomet (ZBH) is one of the most exciting turnaround candidates in the medtech sector for me. After the quarterly results from November 4, the stock jumped by 13.5% on high volume and has since been consolidating at an elevated level. The potential: The established manufacturer of knee and hip implants could increasingly become a leading provider of intelligent surgical systems. With ROSA for knee, hip, and shoulder procedures and the compact knee robot TMINI, Zimmer already has a broad product base. Robotics, data, and AI solutions grew...

Read this article now with a free account.

Your benefits:

  • Every month, you can read 5 articles from the premium section for free.
  • Monthly 2 trial issues of the Trader newspaper for free.
  • Create a personal watchlist with an overview of news about your stock.
Trader Times
Free account
Here we go!
Image 1Image 2Image 3

Already registered? Log In